Maven Securities LTD Annexon, Inc. Transaction History
Maven Securities LTD
- $585 Million
- Q2 2024
A detailed history of Maven Securities LTD transactions in Annexon, Inc. stock. As of the latest transaction made, Maven Securities LTD holds 34,707 shares of ANNX stock, worth $222,818. This represents 0.03% of its overall portfolio holdings.
Number of Shares
34,707
Previous 34,707
-0.0%
Holding current value
$222,818
Previous $170,000
-0.0%
% of portfolio
0.03%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding ANNX
# of Institutions
156Shares Held
101MCall Options Held
3.73MPut Options Held
1.3M-
Bain Capital Life Sciences Investors, LLC Boston, MA8.45MShares$54.2 Million8.47% of portfolio
-
Satter Management Co., L.P.7.41MShares$47.5 Million71.21% of portfolio
-
Bvf Inc San Francisco, CA7MShares$44.9 Million1.05% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$42.3 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.43MShares$41.3 Million2.05% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $306M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...